SUP — Deck

Supreme plc · SUP · LSE

Supreme is a Manchester-based UK fast-moving consumer goods distributor that buys batteries, vaping kit, soft drinks, sports nutrition and household brands at scale and pushes them through grocers, discounters, and convenience retailers.

$2.20
Share price
$258M
Market cap
$299M
Revenue (FY25)
1975
Founded
Listed AIM Feb-2021 at $1.84; ran to $3.30 Dec-2021, collapsed to $0.81 Oct-2022, recovered to $2.71 Jul-2025; round-trip plus 19% above IPO at $2.20.
2 · Variant perception

Priced as a vape distributor; the evidence says UK FMCG roll-up platform

  • Mis-categorised. Vape was 56% of FY25 revenue and the market still treats it as the entire identity — SUP trades at 4.5x EV/EBITDA versus AG Barr at 11x and Nichols at 9.5x on identical 14% operating margins. Non-vape revenue reached roughly half the group at H1 FY26.
  • The flywheel is real. Four bolt-ons closed in fourteen months — Clearly Drinks, Typhoo from administration, 1001 carpet care, SlimFast UK/Europe — at a disclosed 2-4x post-synergy EBITDA. FY25 ROCE held at 39.7% as the asset base nearly doubled.
  • The number that resolves it. Non-vape gross profit needs to clear $54M at the FY26 print to force re-categorisation; FY25 ran at roughly $32M. Below $40M says the platform thesis is intellectually correct but economically inert.
Twice the gross margin, half the multiple — only one of those is allowed to last.
3 · Money picture

30% ROIC, 0.3x leverage, 7.8x earnings — and FCF turns negative once you net out the deals

7.8x
P/E (TTM) 5-yr mean 12.2x
30%
ROIC FY25 top-decile UK FMCG
0.3x
Net debt / EBITDA $52M facility unused
−$4.7M
FCF after acquisitions $33.1M of M&A spend

Headline cash conversion looks clean — three-year cumulative operating cash flow of $90.5M tops cumulative net income of $73.6M at 1.23x. Net $33.1M of FY25 acquisition spend against $32.5M of operating cash, however, and free cash flow flips to negative $4.7M while year-end cash dropped from $15.0M to $4.1M. The 36% gap to the five-year mean P/E either closes on FY26 mean-reversion or the cheap multiple is the market correctly pricing a debt-financed flywheel.

4 · How it got here

From battery distributor to vape windfall to deliberately diluted FMCG platform

Before: Sandy Chadha joined the family business in 1988 at sixteen and spent four decades quietly compounding cash on a base of household batteries (~35% UK share), licensed lighting and 88Vape e-liquid. AIM IPO landed February 2021 at $1.84 with revenue of $168M.

Pivot: Early 2023 the company signed a master-distribution agreement for ElfBar and Lost Mary disposable vapes. By FY24 disposables were 32% of group revenue at $90M and Adjusted EBITDA almost doubled to $48M. Management called the regulatory cliff early and pre-funded the diversification before it hit.

Today: The June 2025 UK disposable ban took effect on schedule, vape revenue still grew 13% in H1 FY26 as refillable pods absorbed the volume, and four bolt-ons in fourteen months rebuilt the company as a three-division platform. The next chapter is whether non-vape gross profit can double from $32M to $54M before the October 2026 vape excise levy lands.

Four decades of batteries, two years of vape, fourteen months of brand-buying — same management team, same warehouse.
5 · Catalyst calendar

Two prints inside seven months decide the rerating debate

  • Mid-late June 2026 — FY26 full-year results. Three open questions resolve on one day: vape revenue durability versus the $167M FY25 base, non-vape gross profit run-rate, and whether acquisition-adjusted FCF returns to positive territory. Management has signposted ~$47M EBITDA on a 15% margin guide, down from FY25's 17.5% print.
  • October-November 2026 — UK vape excise levy. The autumn fiscal event publishes the per-millilitre rate on refillable e-liquid and the treatment of pod systems versus disposables. Pod parity with disposables caps 56% of FY25 revenue at a 4-5x EBITDA multiple permanently; lighter pod treatment removes the largest overhang on the multiple.
  • July-August 2026 — AGM credibility test. BDO faces an eleven-year reappointment vote with no internal audit function in place; the new one-year SIP that paid 93.33% of max gets its first advisory vote. Free-float dissent above 25% on either resolution forces a board commitment; below 10% confirms minorities accept the package.
FY26 results answer the operating question; the levy answers the terminal-value question. Everything else is sizing input.
6 · Bull and Bear

Lean long, wait for confirmation — the operating story is real, the cash-quality ledger is also real

  • For — substitution worked. H1 FY26 vape revenue grew 13% to $103M as disposables collapsed from $13M to $6M; FY25 group gross margin printed an all-time high of 31.9%. The binary regulatory risk that crushed the stock from $2.71 to $1.71 is now observed, not assumed.
  • For — owner-operator economics. Sandy Chadha holds 56% of equity worth roughly 300x his $420k salary; net leverage 0.3x with $52M of the $55M HSBC facility unused; CFO bought 21,000 shares at $1.30 in May 2023. Capacity for another $40-55M bolt-on without strain.
  • Against — the flywheel is debt-financed. FY25 acquisition-adjusted FCF was negative $4.7M; year-end cash fell from $15M to $4M; FY26 added two more deals and triggered the first-ever drawdown on the HSBC facility. Recurring cash currently does not fund both M&A and dividends.
  • Against — vape is a regulated terminal-value pool. Vape is 56% of FY25 revenue and the October 2026 excise levy is the next regulatory shoe; H1 FY26 vape gross margin already slipped from 33% to 31% on the pod transition; the ElfBar/Lost Mary distribution agreement carries ~15% gross margin with no publicly disclosed expiry.
The deciding tension is $33.1M of FY25 acquisition spend that nearly matched $32.5M of operating cash flow — both sides own the same number and read it differently. The H1 FY26 print decides which side is right.

Watchlist to re-rate: H1 FY26 acquisition-adjusted FCF returning to positive territory and DSO dropping back below 55 days; non-vape gross profit run-rate at the FY26 print clearing $54M; pod treatment in the October 2026 vape excise levy structure.